Impact of solriamfetol treatment on sleep quality in Chinese patients with OSA-EDS: results of a randomized controlled trial
No clinically significant or consistent changes in PSG parameters were observed compared with placebo, indicating that solriamfetol morning administration has no significant effect on nocturnal sleep parameters.
Authors
- Fen Wang (ORCID: https://orcid.org/0000-0003-1348-7455)
- Liying Deng
- Yongmin Ding
- Jiaomei Jiang
- Hui Ye
- Weijia Zhang
- Xiang Li
- Liang Xie
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- IGE Therapeutics (United States) (US)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-02-18
- DOI
- https://doi.org/10.3389/fmed.2026.1712097
- Primary Topic
- Obstructive Sleep Apnea Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00